IDH mutant astrocytomas with CDKN2A/B homozygous deletions have significantly shorter survival (Yeo et al., 2023; Brat et al., 2020; Appay et al., 2019; Alentorn et al., 2015). Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).